Helse Fonna   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Haugesund Norway (2002)

Organization Overview

First Clinical Trial
2003
NCT00553293
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

arvid.rongve@helse-fonna.no | Head of Research Department at Helse Finna HF | Helse Fonna | Helse Fonna HF